Literature DB >> 20193183

[The relationship between uncoupling protein 2 expression and myocardial high energy phosphates content in abdominal aorta constriction induced heart failure rats].

Nan Li1, Jiang Wang, Feng Gao, Ai-min Li, Rong Song, Ying Tian, Shan-jun Zhu.   

Abstract

OBJECTIVE: To explore the changes of expression of uncoupling protein 2 (UCP2) in pressure overload induced failure myocardium in rats.
METHODS: Male SD rats were randomized into 3 groups (n = 15 each): abdominal aorta constriction (AC) 20 weeks group (H20w group), sham operation group (SH20w group) and normal control group (N group). Twenty weeks later, myocardial function was evaluated by echocardiography and hemodynamic measurements. Mitochondria in ventricular tissue were isolated by centrifugation. Adenine nucleotide pools (ATP, ADP, AMP, PCr) in myocardium were measured by high performance liquid chromatography. The expression of UCP2 in mitochondria was detected by PT-PCR and Western blot analysis.
RESULTS: Myocardial function was significantly decreased 20 weeks post-AC compared to SH20w group and N group. Myocardial ATP, ADP, AMP and PCr contents were also significantly decreased in H20w group than the other 2 control groups. The expression of UCP2 in myocardial mitochondria was significantly increased in H20w group and negatively correlated with ATP contents (r = -0.929, P < 0.01).
CONCLUSIONS: The expression of UCP2 was upregulated in pressure overload induced failure heart and might be responsible for decreased myocardial adenine nucleotide and energy metabolism disturbance in this model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20193183

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  1 in total

1.  Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression.

Authors:  Chunyan Yang; Dongming Zhao; Guohui Liu; Haikuo Zheng; Hongliang Yang; Sibao Yang; Ping Yang
Journal:  Int J Med Sci       Date:  2018-03-08       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.